COMMUNIQUÉS West-GlobeNewswire

Keryx Biopharmaceuticals Announces Data from an Investigator Sponsored Trial of Ferric Citrate in Patients with Advanced Chronic Kidney Disease in a Late-Breaking Presentation at the 55th Annual ERA/EDTA Today in Copenhagen

25/05/2018 - 12:00

Conference Call Today at 8:30 a.m. EST COPENHAGEN, Denmark, May 25, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a company focused on bringing innovative medicines to people with kidney [...]

CVs of Proposed Members of the Council of JSC Olainfarm

25/05/2018 - 10:09

CVs of Proposed Members of the Council of JSC Olainfarm AINĀRS OZOLS Education: 2005 – 2006 Stockholm School of Economics, Riga. Executive MBA 1997 – 1999 Latvian Banking Academy. The Latvian banking Certificate [...]

MyoGen : Les leaders d’une révolution anabolique

25/05/2018 - 09:44

GUJARAT, Inde, 25 mai 2018 (GLOBE NEWSWIRE) -- Myogen vous fera repenser les limites du corps humain Être un athlète signifie participer à une quête sans fin d’autoamélioration. Une obsession à la recherche d’un [...]

Bardoxolone Methyl Improved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease and IgA Nephropathy in the Ongoing Phase 2 Phoenix Study

25/05/2018 - 09:30

Interim Data Demonstrate Significant Improvement in Kidney Function in Both Diseases Conference Call With Management Scheduled Today, May 25, 2018 at 8:00am ET IRVING, Texas, May 25, 2018 (GLOBE NEWSWIRE) -- Reata [...]

NeuroSearch A/S: Publication of offer document

25/05/2018 - 09:21

Company Announcement 25 May 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]

Vistin Pharma ASA : Last day of the subscription period in the subsequent repair issue

25/05/2018 - 07:31

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

ThromboGenics Enrolls First Patient in Phase 1 Clinical Study Evaluating THR-149, a plasma kallikrein inhibitor, for treatment of Diabetic Macular Edema (DME)

25/05/2018 - 07:31

Press release Leuven, Belgium, 25 May 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that it has successfully enrolled the first [...]

Extendicare Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders and Board Change

25/05/2018 - 00:50

MARKHAM, Ontario, May 24, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced the results of matters voted on at its annual and special shareholders’ meeting held on [...]

Burcon Announces Intention to File Form 25

24/05/2018 - 23:37

VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]

Hydropothecary Announces Acceleration of Warrant Expiry Date

24/05/2018 - 23:00

GATINEAU, Quebec, May 24, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“THCX” or the “Company”) (TSX-V: THCX ) announced today that it has elected to exercise its right under the warrant indenture (the “ [...]

Hydropothecary annonce le devancement de l'échéance de bons de souscription

24/05/2018 - 23:00

GATINEAU, Québec, 24 mai 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (" THCX " ou la " Société ") (TSX CROISSANCE:THCX) a annoncé aujourd'hui qu'elle a choisi d'exercer son droit en vertu de l'acte de fiducie (l [...]

Amarin Announces Patent Litigation Settlement Agreement with Teva

24/05/2018 - 22:35

BEDMINSTER, N.J. and DUBLIN, Ireland, May 24, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Retrophin to Present at Upcoming Investor Conferences

24/05/2018 - 22:30

SAN DIEGO, May 24, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that the Company’s management team will present at the following upcoming investor conferences in June: Jefferies 2018 Global [...]

Kane Biotech to Present at TakeStock! Investor Forum

24/05/2018 - 22:30

Forum Held May 31 in Association with TSX Venture Exchange WINNIPEG, Manitoba, May 24, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce [...]

ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split

24/05/2018 - 22:01

EDISON, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

Ogilvy CommonHealth Worldwide’s Johanna Skilling and Jennifer Werther to be honored at MM&M’s 2018 Hall of Femme ceremony

24/05/2018 - 20:35

PARSIPPANY, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced Johanna Skilling, head of [...]

I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada

24/05/2018 - 19:36

MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution agreement with ESW Vision [...]

I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada

24/05/2018 - 19:36

MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer l’officialisation d’une entente [...]

Announcement from Xbrane Biopharma's annual general meeting

24/05/2018 - 19:07

Press release 2018-05-24 The annual general meeting (" AGM ") of Xbrane Biopharma AB (" Xbrane " or the " Company ") was held today on 24 May 2018 and the following resolutions were passed by the meeting. Adoption of [...]